ECHOIQ LIMITED (EIQ)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

EIQ

EIQ - ECHOIQ LIMITED

FNArena Sector : NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: -0
Index: ALL-TECH

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.25

28 Nov
2025

0.005

OPEN

$0.25

2.04%

HIGH

$0.25

1,160,308

LOW

$0.24

TARGET
$0.40 60.0% upside
FNARENA'S MARKET CONSENSUS FORECASTS
EIQ: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx - 2.3 - 1.1 xxx
DPS (cps) xxx 0.0 N/A xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx-2.3
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx0.1 M
Book Value Per Share xxxxxxxxxxxxxxx3.5
Net Operating Cash Flow xxxxxxxxxxxxxxx-6.5 M
Net Profit Margin xxxxxxxxxxxxxxx-13,078.24 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx-89.84 %
Return on Invested Capital xxxxxxxxxxxxxxx-89.84 %
Return on Assets xxxxxxxxxxxxxxx-83.87 %
Return on Equity xxxxxxxxxxxxxxx-89.84 %
Return on Total Capital xxxxxxxxxxxxxxx-100.53 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-6.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx0 M
Long Term Debt xxxxxxxxxxxxxxx0 M
Total Debt xxxxxxxxxxxxxxx0 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx7 M
Price To Book Value xxxxxxxxxxxxxxx6.24

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx0.0 M
Capex % of Sales xxxxxxxxxxxxxxx35.30 %
Cost of Goods Sold xxxxxxxxxxxxxxx1 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx14 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Ord Minnett

25/11/2025

1

Speculative Buy

$0.40

60.00%

EchoIQ has completed the EchoSolv HF validation study with Mayo Clinic, with Ord Minnett noting the study met its primary endpoint and exceeded expectations and competitor benchmarks.

The results leave the business well-placed to become the "best-in-breed echocardiographic AI provider in heart failure", the broker adds.

As reimbursement is already in place and there is a growing US installed base, Ord Minnett continues to envisage 2026 as a big year for the company and maintains a Speculative Buy rating. Target is $0.40.

FORECAST
Ord Minnett forecasts a full year FY26 EPS of minus -1.10 cents.
Ord Minnett forecasts a full year FY27 EPS of minus -0.10 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

EIQ STOCK CHART

FNArena News on EIQ

1
Dr Boreham’s Crucible: Hydrix

Mar 26 2024 - Small Caps